Description

Technical Parameters

Product Introduction

Our Semaglutide Weight Loss Tablets is a significant advancement in medication, developed using our world-leading oral delivery technology. This innovative approach allows for the effective oral absorption of biopharmaceuticals, a challenging feat achieved through precise targeted delivery mechanisms.

Research Data

[Biovailability in Beagle Dog: Single-dose h2h PK study]

product-1110-375

The AUC of BO-017 mg capsule is 12 times higher than the Rybelsus 7 mg tablet.

[Primate research data: Comparison of promate absorption after a single dose]

Item	Specification	Subject	Number	AVG Cmax (ng/ml)	AVG T1/2 (hours)	Bioavailability
Rybelsus	5 mg	normal	n=24	8.3	7.94	0.4~1%⁽³⁾
Rybelsus	7 mg	normal	n=6	4.37	/	0.4~1%⁽³⁾
BO-01	7 mg	normal	n=5	62.6	51.6	/

(1)Originated from Rybelsus EMA NDA data
(2)In-house data
(3)Originated from Rybelsus FDA NDA data
BO-01 displayed~8 times higher than Rybelsus when concerning their single-dose Cmax.
BO-01 displayed~7 times higher than Rybelsus when concerning their single-dose T1/2.

Project Cooperation

Technique License-out
In our technique license-out program, we offer the following advantages for partnering with us:
(1)Client's Polypeptide: We collaborate on advancing and commercializing your specific polypeptide molecules, leveraging our expertise in formulation and delivery.
(2)Type 1 Original Drug: We provide opportunities for licensing out original drug formulations, ensuring regulatory compliance and efficacy through our established processes.
(3)Milestone Fee: Our partnership includes structured milestone payments, rewarding progress and achievements throughout the development and regulatory stages.
This approach ensures a collaborative and mutually beneficial path towards bringing innovative therapies to market.

Certificate Display

product-1561-480

Exhibition Photos

product-1562-559

Company Profile

product-1561-649

FAQ

Q: 1.Why is Semaglutide so popular?

A: This medicine is one of the most exciting changes in obesity medicine ever. The gold standard for obesity used to be metabolic surgery. We are now seeing drugs like Mounjaro® that mimic the effect of weight loss surgery with patients losing up to 20% of their body weight.
Available by injection (most popular) or in a pill form, semaglutide drugs work by mimicking the hormone GLP-1, which serves many functions like triggering insulin release, preventing glucose from entering the bloodstream, slowing digestion, and increasing the feeling of fullness. Patients report feeling much less hungry day-to-do and unable to eat the same volume of food they once did.

Q: 2.Who is eligible to take Semaglutide?

A: The FDA recommends GLP-1s for weight loss if you meet one of the following criteria:
●Have a body mass index (BMI) of 27kg/m2 or greater and at least one weight-related condition, such as high blood pressure, Type 2 diabetes or high cholesterol
●Have a BMI of 30kg/m2 or greater
If you're thinking about semaglutide for weight loss, your first step should be consulting your primary care physician (PCP) or an obesity specialist such as Dr. Peterson. They will review your medical history and can guide you in the best treatment options. If you have diabetes and already take a different medication, talk to your physician about safe drug combinations.

Hot Tags: semaglutide weight loss tablets, China semaglutide weight loss tablets manufacturers, suppliers, 41263-94-9, Coenzyme Q10 Powder, Oseltamivir Phosphate Suspension and Capsule, N octyltriethoaysilane N308 , 823202-99-9, Milk Exosomes